Latest Share Chat

REMOVE ADS

Avacta Group Share News (AVCT)

Avacta Group Information

Share Price Information for Avacta Group (AVCT)

Share Price is delayed by 15 minutes

Get Live Data

72.50 2.50 (3.57%)

Bid:

71.00

Ask:

74.00

Spread: 3.00 (4.225%)

Market Cap: £329.95m

Last checked at -

Intraday Avacta Group Share Chart

REMOVE ADS

Avacta Group News

Avacta upbeat on fresh data from chemotherapy trial

(Sharecast News) - Life sciences company Avacta Group announced the successful completion of its sixth dose escalation cohort in the ALS-6000-101 phas...

Avacta notes "excellent" safety profile for prospective sarcoma drug

(Alliance News) - Avacta Group PLC on Tuesday said it successfully completed the sixth dose escalation of the ALS-6000-101 phase 1 clinical trial, in ...

IN BRIEF: Avacta Group issues 3.8 million shares to make repayment

Avacta Group PLC - Wetherby, England-based life sciences company developing targeted oncology drugs and diagnostics - Issues 3.8 million new shares of...

UK shareholder meetings calendar - next 7 days

Avacta completes fifth dose escalation in chemotherapy trial

(Sharecast News) - Life sciences company Avacta announced the successful completion of the fifth dose escalation cohort in the phase 1 clinical trial ...

Avacta says AVA6000 fifth dose escalation results "very favourable"

(Alliance News) - Avacta Group PLC on Wednesday said it has completed the fifth dose escalation cohort in its phase 1 clinical study of AVA6000.

IN BRIEF: Avacta says no fundraising imminent after market speculation

Avacta Group PLC - Wetherby, England-based life sciences company developing targeted oncology drugs and diagnostics - Reponds to recent market specula...

Avacta denies press speculation over potential fundraising

(Sharecast News) - Oncology drug developer Avacta Group responded to recent market speculation over a potential fundraising initiative on Monday.